Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2007

Conditions
Radiculopathy
Interventions
DRUG

Lenalidomide (CC-5013)

Lenalidomide 2-5 mg capsules taken one time per day

Trial Locations (23)

11554

North Shore University Hospital, Bethpage

14642

University of Rochester Medical CenterPain Services, Rochester

19102

Drexel University College of MedicineDepartment of Neurology Rm 7102, Philadelphia

21205

Johns Hopkins Pain Center, Baltimore

22903

University of Virginia Pain Management Center, Charlottesville

27103

Carolinas Pain Institute, P.A. & the Center for Clinical Research, LLC, Winston-Salem

27705

Duke University Medical Center, Durham

30322

Emory University Hospital, Atlanta

32905

Space Coast Neurology, Palm Bay

33331

Gold Coast Research, LLC, Weston

45432

Research Institute of Greater Dayton, Dayton

52242

University of Iowa, Iowa City

55905

Mayo Clinic, Rochester

60611

Rehab Institute of Chicago, Chicago

63141

Washington University Pain Mgmt Ctr, St Louis

75080

KRK Medical Research, Richardson

79430

Texas Tech Medical Center Department of Anesthesiology, Lubbock

85023

Arizona Research Center, Phoenix

85741

Genova Clinical Research, Inc, Tucson

92354

Loma Linda Institution, Loma Linda

98104

Swedish Pain Services, Seattle

18103-6208

Attn: Maryjane CerroneLehigh Valley Hospital, Allentown

05403

Fletcher Allen Healthcare for Pain Medicine, South Burlington

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY